Scientist.com announces its COMPLi® solution has expanded to include Animal Welfare as part of its effort to ensure that any non-human animals involved in scientific research are handled ethically and humanely. COMPLi® is a first-of-its-kind solution that allows pharmaceutical and biotechnology companies to confidently outsource regulated services such as toxicology studies, human biological sample acquisition, secondary real-world evidence (RWE), health economics and outcomes research (HEOR), and any GxP (e.g., GLP and GCP) service.
“Our new COMPLi Animal Welfare due diligence process was created to ensure that marketplace suppliers who provide in vivo services treat animals involved in scientific research in an ethical and humane way,” said Matt McLoughlin, VP of Compliance at Scientist.com. “We are working with several research organizations to drive transparency, educate researchers and help create standards for the entire industry.”
Launched in 2017, COMPLi helps researchers and suppliers adhere to internal and external (often legislative) procurement policies and regulations. It ensures that, where required, appropriate ethical considerations are addressed, tracked and communicated throughout the supply chain. COMPLi addresses compliance and governance requirements at every key step of the sourcing process to speed up drug research and reduce the risks of outsourcing. In 2018, the online compliance solution received a prestigious CPhl Award in the Regulatory Procedures and Compliance category.